Genedata Announces New Solution for CRISPR Data Management and AnalysisBenzingaGenedata, a leading provider of advanced software solutions for R&D, today announced the release of Genedata Selector for Precise Genome Editing, an innovative solution … Continue reading
|
Few Patients Get CAR T Cells Because of ‘Insurance Snags’
Medscape Although clinical responses have been remarkable and the approval by the US Food and Drug Administration (FDA) of these novel therapies was heralded as the biggest medical news of last year, it appears that chimeric antigen receptor (CAR) T-cell … |
|
Few Patients Get CAR T Cells Because of ‘Insurance Snags’
Medscape Although clinical responses have been remarkable and the approval by the US Food and Drug Administration (FDA) of these novel therapies was heralded as the biggest medical news of last year, it appears that chimeric antigen receptor (CAR) T-cell … |
Medscape |
Few Patients Get CAR T Cells Because of ‘Insurance Snags’
Medscape Although clinical responses have been remarkable and the approval by the US Food and Drug Administration (FDA) of these novel therapies was heralded as the biggest medical news of last year, it appears that chimeric antigen receptor (CAR) T-cell … |
WBUR |
New Cancer Treatments Top $500000, Raise Daunting Questions About How To Pay
WBUR It’s one of the most effective cancer treatments so far. And one of the most expensive cancer drugs ever. That’s why cancer specialists are both excited about so-called CAR–T cell therapy — and worried about what it portends for the affordability of … |
Independent |
CRISPR-Cas: Genetic engineering’s Holy Grail
Independent COMMENT | TECHNOLOGY | Antoine Danchin | Since its introduction four decades ago, genetic engineering has been a source of high hopes for health, agriculture, and industry. But it has also provoked deep anxiety, not least owing to the laborious nature … |